Applications
Olink technology is being applied by scientists around the world for more effective drug discovery & development, to drive clinical research and increase our understanding of human biology.
Incomplete knowledge of the real-time biology underlying disease and drug action can drive up costs and time in drug development. Protein biomarkers, along with other omics markers, can be used to predict response, stratify patient populations, and provide insights into the biology of disease.
Researchers from Alnylam Pharmaceuticals use large scale protein biomarker discovery to identify a novel biomarker for hereditary transthyretin-mediated (ATTRv) amyloidosis disease onset and progression.
Multiomics approaches are increasingly being applied to tackle the big biological questions, and the combination of proteomics with genomics in particular is opening up new possibilities for better drug target identification.
See how Olink has collaborated with the research community to enable proteomic and multiomic studies providing vital insights into the underlying biology of disease severity, progression and recovery in COVID-19.
Predictive biomarkers remain a rapidly emerging area of research in immunotherapy. See how Olink is being used to identify minimally invasive protein biomarkers to monitor responses and predict outcomes in cancer immunotherapy
The inaccessibility of the brain and the relative scarcity of definitive physical parameters for clinical evaluation represent major challenges when it comes to neurological conditions such as neurodegenerative diseases and chronic pain.
Olink is being been increasingly incorporated into systems biology approaches to big biological questions, integrating proteomics with genomics, transcriptomics and other omics applications to get a bigger picture view and gain actionable insights.
Olink protein biomarker analysis and mass cytometry were combined to gain a systems-level understanding of early immune system development in newborn children by combining protein and cellular analysis.
Customer stories
Olink customers have some fascinating stories to tell about the incredible research they are doing with the help of actionable insights into their biological questions from protein biomarker discovery and analysis. Head over to the “Our community” page to see how these stories are making a difference across a broad range of disease areas and biological questions, as well as helping to drive the development of future therapies.
2947
Biomarker assays
~881 million
Protein data points generated
1281
Publications listed on website